agilon health (NYSE:AGL) Trading Up 9.6% – Still a Buy?

agilon health, inc. (NYSE:AGL) was up 9.6% during mid-day trading on Friday . The stock traded as high as $2.12 and last traded at $2.11. Approximately 2,120,714 shares were traded during trading, an increase of 16% from the average daily volume of 1,826,953 shares. The stock had previously closed at $1.92.

Analysts Set New Price Targets

A number of analysts have commented on the stock. Citigroup cut their price objective on shares of agilon health from $2.50 to $1.75 and set a “sell” rating for the company in a report on Wednesday, November 13th. William Blair cut shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday, November 8th. Royal Bank of Canada reiterated an “outperform” rating and issued a $3.00 price objective on shares of agilon health in a report on Tuesday, November 19th. TD Cowen lowered their price objective on agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a research report on Monday, November 11th. Finally, Stifel Nicolaus reduced their target price on agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a research report on Tuesday, November 12th. Three equities research analysts have rated the stock with a sell rating, sixteen have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $4.28.

agilon health Price Performance

The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The company’s 50 day moving average is $2.10 and its 200 day moving average is $3.90. The stock has a market cap of $861.12 million, a price-to-earnings ratio of -2.22 and a beta of 0.51.

agilon health (NYSE:AGL) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The firm had revenue of $1.45 billion during the quarter, compared to analysts’ expectations of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same period in the previous year, the business earned ($0.06) earnings per share. Research analysts forecast that agilon health, inc. will post -0.52 earnings per share for the current fiscal year.

Insider Transactions at agilon health

In other agilon health news, Director Karen Mcloughlin purchased 25,000 shares of agilon health stock in a transaction on Friday, December 13th. The shares were purchased at an average cost of $2.20 per share, with a total value of $55,000.00. Following the completion of the transaction, the director now directly owns 73,166 shares in the company, valued at approximately $160,965.20. This represents a 51.90 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director John William Wulf acquired 45,000 shares of the business’s stock in a transaction on Thursday, December 5th. The stock was bought at an average cost of $2.18 per share, for a total transaction of $98,100.00. Following the completion of the transaction, the director now directly owns 206,133 shares of the company’s stock, valued at $449,369.94. This trade represents a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased a total of 90,000 shares of company stock valued at $198,100 over the last three months. 3.20% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of AGL. Point72 Asia Singapore Pte. Ltd. acquired a new position in agilon health during the 3rd quarter worth $28,000. City State Bank bought a new stake in agilon health during the 3rd quarter valued at $52,000. Allspring Global Investments Holdings LLC increased its holdings in shares of agilon health by 17,790.0% during the second quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company’s stock valued at $70,000 after purchasing an additional 10,674 shares during the period. CIBC Asset Management Inc bought a new stake in agilon health during the second quarter worth approximately $78,000. Finally, Aigen Investment Management LP bought a new stake in agilon health in the third quarter worth about $79,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.